0.1 |
0.6 |
GO:0042117 |
monocyte activation(GO:0042117) |
0.1 |
0.4 |
GO:0035905 |
ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.1 |
0.3 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
0.1 |
0.3 |
GO:0019046 |
release from viral latency(GO:0019046) regulation of DNA strand elongation(GO:0060382) |
0.1 |
0.3 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) platelet dense granule organization(GO:0060155) |
0.1 |
0.3 |
GO:1905223 |
epicardium morphogenesis(GO:1905223) |
0.1 |
0.3 |
GO:0007525 |
somatic muscle development(GO:0007525) |
0.1 |
0.4 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
0.1 |
0.4 |
GO:0071694 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 |
0.6 |
GO:0002158 |
osteoclast proliferation(GO:0002158) |
0.1 |
0.5 |
GO:0006265 |
DNA topological change(GO:0006265) |
0.1 |
0.3 |
GO:0061641 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.1 |
0.2 |
GO:0043387 |
mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
0.1 |
0.3 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.0 |
0.3 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
0.0 |
0.1 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
0.0 |
0.3 |
GO:0070294 |
renal sodium ion absorption(GO:0070294) |
0.0 |
0.2 |
GO:1904049 |
negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.0 |
0.2 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
0.0 |
0.2 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.0 |
0.2 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
0.0 |
0.2 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
0.0 |
0.1 |
GO:2000182 |
regulation of progesterone biosynthetic process(GO:2000182) |
0.0 |
0.1 |
GO:0040030 |
regulation of molecular function, epigenetic(GO:0040030) |
0.0 |
0.1 |
GO:0061314 |
Notch signaling involved in heart development(GO:0061314) |
0.0 |
0.2 |
GO:0045876 |
positive regulation of sister chromatid cohesion(GO:0045876) |
0.0 |
0.2 |
GO:0014854 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 |
0.1 |
GO:0003130 |
BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) embryonic heart tube anterior/posterior pattern specification(GO:0035054) corticotropin hormone secreting cell differentiation(GO:0060128) |
0.0 |
0.5 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.0 |
0.1 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
0.0 |
0.4 |
GO:0032328 |
alanine transport(GO:0032328) |
0.0 |
0.1 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
0.0 |
0.3 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
0.0 |
0.1 |
GO:0060031 |
mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.0 |
0.1 |
GO:0021763 |
subthalamic nucleus development(GO:0021763) superior vena cava morphogenesis(GO:0060578) |
0.0 |
0.2 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
0.0 |
0.1 |
GO:0021666 |
rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.0 |
0.2 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.0 |
0.1 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.0 |
0.1 |
GO:0031660 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
0.0 |
0.1 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.0 |
0.2 |
GO:0051665 |
membrane raft localization(GO:0051665) |
0.0 |
0.2 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
0.0 |
0.3 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
0.0 |
0.2 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 |
0.1 |
GO:1903918 |
regulation of actin filament severing(GO:1903918) negative regulation of actin filament severing(GO:1903919) |
0.0 |
0.2 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 |
0.3 |
GO:0007141 |
male meiosis I(GO:0007141) |
0.0 |
0.1 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
0.0 |
0.1 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
0.0 |
0.1 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 |
0.1 |
GO:0044849 |
estrous cycle(GO:0044849) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.0 |
0.2 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
0.0 |
0.2 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
0.0 |
0.1 |
GO:0014850 |
response to muscle activity(GO:0014850) |
0.0 |
0.2 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
0.0 |
0.3 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
0.0 |
0.1 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
0.0 |
0.1 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |